SFS
DWTX

Sowell Financial Services’s Dogwood Therapeutics DWTX Stock Holding History

Sowell Financial Services’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-122
Closed -$15K – 2828
2021
Q1 		$15K Buy
+122
New +$21.2K ﹤0.01% 2177

Other funds holding DWTX

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sowell Financial Services's DWTX Position: Q2 2021 in Review

Sowell Financial Services sold out of Dogwood Therapeutics (DWTX) in Q2 2021, closing a stake of 122 shares — an estimated $15K sold.

Sowell Financial Services first reported a position in DWTX in Q1 2021 and held it in 1 quarter. The position peaked at $15K in Q1 2021. 14 funds tracked by Wall St. Rank hold DWTX as of Q2 2021.

  • Sowell Financial Services reported no remaining Dogwood Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 122 Dogwood Therapeutics shares in Q2 2021, an estimated $15K.
  • Sowell Financial Services first reported a position in Dogwood Therapeutics in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Dogwood Therapeutics position peaked at $15K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.